StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report sent to investors on Friday morning. The brokerage issued a hold rating on the stock.
China Pharma Stock Performance
Shares of CPHI stock opened at $0.27 on Friday. The stock has a 50-day simple moving average of $0.32 and a 200 day simple moving average of $0.42. China Pharma has a fifty-two week low of $0.26 and a fifty-two week high of $2.18. The company has a quick ratio of 0.25, a current ratio of 0.89 and a debt-to-equity ratio of 0.17.
China Pharma (NYSE:CPHI – Get Free Report) last announced its earnings results on Wednesday, May 15th. The company reported ($0.07) earnings per share for the quarter. China Pharma had a negative net margin of 55.42% and a negative return on equity of 54.31%. The firm had revenue of $1.37 million for the quarter.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
See Also
- Five stocks we like better than China Pharma
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- MarketBeat Week in Review – 6/3 – 6/7
- The How and Why of Investing in Gold Stocks
- Geron Corporation: FDA Approval Fuels Stock Price Surge
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Intel’s Secret Plan for a Double-Digit Stock Rally Revealed
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
